Target intelligence / Profile preview

Growth differentiation factor (GDF)

Target
GDF
Molecular classification
Other (secreted growth factor), Cytokine, Member of Transforming Growth Factor-beta (TGF-β) superfamily
01

Overview

Growth differentiation factors" are a family of secreted signaling proteins within the transforming growth factor-beta (TGF-β) superfamily, with members individually designated as GDF1 through GDF15. Each GDF regulates diverse aspects of embryonic development, organogenesis, tissue differentiation, and adult homeostasis. For example, GDF8 (myostatin) inhibits skeletal muscle growth, GDF11 is involved in neurogenesis and tissue regeneration, and GDF15 acts as a stress-induced regulator implicated in inflammation, cancer, and cardiovascular disease[1][2][3][4][5][9]. Most GDFs act via serine/threonine kinase "type I and II" TGF-β family receptors to activate pathways such as Smad-dependent gene transcription. Several GDFs are validated therapeutic targets (e.g., myostatin/GDF8 in muscle wasting, GDF15 in cachexia and cancer immunomodulation), and some (notably GDF15) are used as biomarkers for disease prognosis or therapy guidance. GDF15, in particular, can suppress appetite and is explored for metabolic disease therapies, though this effect also raises safety issues for unintended weight loss[9][4]. Clarification: - **is_incorrect**: true. "Growth differentiation factor" refers to a subfamily, not a single, unique molecular entity. Structured data should refer to a specific member (e.g., "Growth differentiation factor 11" or "Myostatin (growth differentiation factor 8)") for clarity and actionable annotation[1]. - **canonical_abbreviation**: "GDF" is an abbreviation for the family; each member has its own (e.g., GDF11, GDF15)[1][9]. - **Aliases**: Full aliases are only meaningful at the level of specific members. To obtain structured, precise information, the query should be for a particular GDF member.

Other names
Growth differentiation factor (GDF)growth differentiation factor 1 (GDF1)growth differentiation factor 2 (GDF2/BMP9)growth differentiation factor 3 (GDF3/Vgr-2)growth differentiation factor 5 (GDF5/CDMP1)growth differentiation factor 6 (GDF6)growth differentiation factor 8 (GDF8/myostatin)growth differentiation factor 9 (GDF9)growth differentiation factor 10 (GDF10/BMP-3b)growth differentiation factor 11 (GDF11)growth differentiation factor 15 (GDF15/TGF-PL, MIC-1, PDF, PLAB, PTGFB)
02

Mechanism of action

Modulation through agonism/antagonism of GDF signaling (e.g., antibodies, ligand traps); Signal transduction via TGF-β/Smad pathways, downstream of type I and II serine/threonine kinase receptors.

03

Biological functions

Developmental regulationEmbryogenesisCell differentiationCell proliferationMuscle growth regulationOvulationIron metabolismInflammatory responseApoptosisSignal transduction
04

Disease associations

CancerCardiovascular diseaseKidney diseaseNeurodegenerative diseasesAge-related diseaseMusculoskeletal disordersInflammationObesityFertility disorders
05

Safety considerations

Potential for off-target effects and pleiotropic actions given essential developmental and homeostatic functionsModulation can affect muscle, cardiovascular, and metabolic systemsCancer risk with chronic inhibition in some contextsAnorexia associated with GDF15 overactivity
06

Interacting drugs

None specifically approved as direct GDF inhibitors or agonists, though research and therapeutic modulation (especially of GDF11, GDF15, myostatin/GDF8) is ongoing in clinical and preclinical studies
07

Biomarkers

GDF15 is an emerging biomarker for cardiovascular disease, kidney disease, and some cancersGDF11 levels are studied as aging biomarkers

Beyond the preview

Go deeper on Growth differentiation factor (GDF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Growth differentiation factor (GDF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call